Seiten sind aktuell sortiert nach: Datum (erst neue Artikel)
Rising geriatric population, growing prevalence of chronic diseases, increasing number of diagnostic centers, and increasing physician awareness & demand for histopathology are expected to fuel the growth of this market in the coming years. Rapid growth in the developing countries across APAC and Latin America and the increasing demand for personalized medicine offer significant growth opportunities in the immunohistochemistry market. What is growth in Immunohistochemistry Market ? The global immunohistochemistry market is projected to reach $2.12 billion by 2021, at a CAGR of 7.3%. Howe ...
Anlässlich der sechsten Aufstockung des Global Fund verkündete (RED) heute eine Erhöhung der Zusage für den Global Fund über die nächsten drei Jahre von 150 Mio. $. Das sind 50 % mehr als die 100 Mio. $, die bei der letzten Aufstockung 2016 zugesagt wurden. (RED) hat bislang bereits mehr als 600 Mio. $ mobilisiert. Die Ankündigung markiert eine Aufstockung der Hilfszusagen der Partner aus dem privaten Sektor, um die lebensrettende Arbeit des Global Fund im Kampf gegen AIDS zu unterstützen. (RED)s Chief Operating Officer, Jennifer Lotito, sagte: "Führende Politiker haben bereit ...
The global Craniomaxillofacial Implants market is segmented on the basis of type, application site, material of construction, property and regions. The craniomaxillofacial implants market is witnessing high growth due to factors such as are increasing number of road accidents, trauma cases, rising demand for minimally invasive reconstruction surgeries, rising prevalence of congenital facial deformities, and technological advancements. Based on type, application site, material of construction, property, and regions. The type segment is further classified into mid face implants, mandibular orth ...
The global Dental Digital X-ray market is segmented on the basis of application, type, end user and region. Factors such as technological advancements, rapidly growing geriatric population, ability of digital systems to reduce diagnosis time and provide improved image quality, growing adoption of cone-beam computed tomography (CBCT), increase in dental disorders, and the growing demand for cosmetic dentistry are propelling the market of dental digital X-ray during the forecast period. On the basis of type, the market is segmented into extraoral X-ray systems and hybrid X-ray systems. The extr ...
Emerging markets such as China, India, and Japan are the key areas of opportunity for players in this market. However, stringent clinical & regulatory processes and unfavorable healthcare reforms in the US are expected to restrain the growth of this market during the forecast period. Factors such as the increased funds & grants by government bodies worldwide for the development of novel biomaterials, rising demand for medical implants, and the rising incidence of cardiovascular diseases are driving the growth of the market. The global biomaterial market is projected to reach $207 bil ...
The global Cell Expansion market is segmented on the basis of type, cell type, end user and region. Growth in this market is largely driven by the rising global prevalence of cancer, growing awareness regarding cell-based therapies, and increasing government funding cell-based studies. On the basis of type, the market is segmented into consumables and instruments. In 2018, the consumables segment accounted for the largest share of the market. This is mainly due to its high demand during the production of regenerative medicine and rising research activities on stem cells in the biopharmaceutic ...
The global Specialty PACS market is segmented on the basis of type, deployment model, component, end user, and region. The growth in this market is driven mainly by the increasing geriatric population and subsequent growth in the incidence of various diseases, advantages associated with specialty PACS, government initiatives to increase the adoption of healthcare IT solutions, growing investments in medical imaging, rising adoption of medical imaging IT solutions, and increasing use of imaging equipment. Based on the type, the specialty PACS market is segmented into radiology PACS, cardiolog ...
Fokale Therapien wie das Tookad®-Verfahren gelten bei der Behandlung des Niedrigrisiko-Prostatakarzinoms als wegweisend: Das Organ bleibt erhalten, lediglich das Tumorgewebe wird zerstört. Sie sind Alternativen für Patienten, die keine radikale Behandlung benötigen, die aber mehr als eine aktive Überwachung wünschen. Auf dem 71. DGU-Kongress in Hamburg gab es Neuigkeiten zum Tookad®-Verfahren. Im wissenschaftlichen Programm sprachen Prof. Dr. Christian Thomas, Dr. Angelika Borkowetz und Dr. Stefan Propping über die Tookad®-Therapie und ihre Erfahrungen aus 27 Behandlungen in der Kl ...
Advanced BioScience Laboratories, Inc. (ABL), ein globales Auftragsentwicklungs- und Produktionsunternehmen für Biotherapeutika und Impfstoffe, hat heute bekanntgegeben, dass das Unternehmen einen IDIQ-Vertrag (Indefinite Delivery, Indefinite Quantity, dt. ohne feste Lieferfristen und -mengen) vom National Cancer Institute (NCI) des National Institutes of Health (NIH) im Rahmen seines präklinischen Entwicklungsprogramms für Krebswirkstoffe PREVENT erhalten hat (cGMP Production of Vaccines and Biologicals for Cancer Prevention, Solicitation Number: N01CN87006-18). Der auf 4 Jahre angele ...
PurHealthRX ® gab den Abschluss der ersten großen klinischen Studie bekannt, bei der die Anti-Aging-Wirkungen und die Sicherheit von Vollspektrum-Hanf CBD-Öl bei menschlichen Probanden untersucht wurden. Die Studie wurde mit Unterstützung des National Institute of Health (NIH) durchgeführt. Die randomisierte Placebo-kontrollierte Studie unter 150 Patienten zeigte, dass Vollspektrum-Hanf CBD-Öl einen signifikanten Effekt auf eine Reihe von Anti-Aging-bezogener Faktoren hatte. Im Rahmen der Studie wurden Entzündungsmarker, Herz-Kreislauf- und Stoffwechsel-Indikatoren untersucht, wäh ...
According to the new market research “Aspiration and Biopsy Needles Market by Product (Fine-needle Aspiration, Biopsy (Core & Vacuum Assisted)), Site, Procedure (Image-guided (Ultrasound, MRI, Stereotactic), Nonimage-guided), End user (Hospital, Academia) - Global Forecast to 2024", analyzes and studies the major market drivers, restraints/challenges, and opportunities. The aspiration and biopsy needle market is estimated to grow at a CAGR of 7.3% to reach USD 1,272 Million by 2024 from USD 894 Million in 2019. The global Aspiration and Biopsy Needles market is segmented based on pr ...
According to the new market research “Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services), Application (Cell Biology, Stem Cells, Drug Discovery), End User (Pharmaceutical & Biotechnology Companies, Research Institutes) - Global Forecasts to 2023", analyzes and studies the major market drivers, restraints/challenges, and opportunities. The global live cell imaging market is expected to reach USD 2.9 billion by 2023 from an estimated USD 1.9 billion in 2018, at a CAGR of 8.9%. The global Live Cell Imaging market is segmented based on product, application ...
According to the new market research “Cell Surface Markers Market by Product (Antibody, PCR Array), Source (Mice, Rat), Cell Type (T cells, B cells, NK cell), Application (Research (Stem Cell, Immunology), Clinical (Oncology, Hematology)), and End User (Hospitals) - Global Forecast to 2023", analyzes and studies the major market drivers, restraints/challenges, and opportunities. The cell surface markers market is valued at an estimated USD 520 million in 2018 and is projected to reach USD 769 million by 2023, at a CAGR of 8.1% during the forecast period. The global Cell Surface Markers m ...
According to the new market research “Real World Evidence Solutions Market by Component (Dataset (Claims, Clinical, Pharmacy, Patient), Services), Therapeutic Area (Oncology, Cardiovascular, Immunology), End User (Pharmaceuticals, Medical Devices, Payers, Providers) - Global Forecast to 2023", analyzes and studies the major market drivers, restraints/challenges, and opportunities. The global real-world evidence market is valued at 612.0 million in 2017 and projected to reach USD 1,348.1 million by 2023, at a CAGR of 14.3%. The global Real World Evidence Solutions market is segmented ba ...
According to the new market research “Cerebrospinal Fluid Management Market by Product (Shunts (Ventriculoperitoneal, Ventriculoatrial, Adjustable Valve), External Drainage Systems (EVD, Lumbar Drainage)), End User (Pediatric, Adult, Geriatric) - Global Forecast to 2022", analyzes and studies the major market drivers, restraints/challenges, and opportunities. The global cerebrospinal fluid management market was valued at USD 1.20 Billion in 2016 and is projected to reach USD 1.56 Billion by 2022, at a CAGR of 4.4%. The global Cerebrospinal Fluid Management market is segmented based on pr ...
According to the new market research “CRISPR Technology Market by Product (Enzymes, Kits, gRNA, Libraries, Design Tools), Service (gRNA Design, Cell Line Engineering), Application (Biomedical, Agricultural), End User (Pharma & Biopharma Companies, Academics, CROs) - Global Forecast to 2023", analyzes and studies the major market drivers, restraints/challenges, and opportunities. The CRISPR technology market is expected to grow from USD 562 million in 2018 to USD 1,715 million by 2023, at a CAGR of 25% during the forecast period. The global CRISPR Technology market is segmented based ...
The major factors driving the growth of the Live Cell Encapsulation Market are the rising public awareness related to the clinical role of encapsulated cells in disease management, increasing public-private investments to support product development, and the rising adoption of novel drug delivery systems for disease treatment. According to the new market research report "Live Cell Encapsulation Market by Technique (Dripping (Simple, Electrostatic), Coaxial Airflow, Liquid Jet), Polymer (Alginate, Chitosan, Silica, Cellulose Sulfate), Application (Probiotics, Transplant, Drug Delivery, Re ...
- Medicago, ein in der Entwicklung und Herstellung von pflanzlichen Impfstoffen weltweit führendes Biotechnologie-Unternehmen mit Sitz in Quebec City, gibt bekannt, dass Health Canada seinen Zulassungsantrag (NDS) für einen pflanzlichen, rekombinanten, quadrivalenten, virusähnlichen (QVLP) Grippeimpfstoff zur wissenschaftlichen Prüfung genehmigt hat. "Dies ist ein wichtiger Schritt auf dem Weg zur Vermarktung", sagt Dr. Bruce Clark, Präsident und Chief Executive Officer von Medicago. "Die Genehmigung unseres Zulassungsantrags gibt uns die Möglichkeit, einen innovative ...
According to the new market research “Creatinine Measurement Market by Product (Kits, Reagents), Test Type (Jaffe method, Enzymatic creatinine method), Sample (Serum Creatinine, Urine) and End User (Hospitals, Diagnostic Laboratories), Region (North America, Europe) - Global Forecast to 2023", analyzes and studies the major market drivers, restraints/challenges, and opportunities. The global creatinine measurement market is expected to reach USD 564.5 Million by 2023 from USD 349.9 Million in 2017, at a CAGR of 8.4%. The global Creatinine Measurement market is segmented based on product ...
According to the new market research “Hemostats Market by Product (Thrombin, Oxidised Regenerated Cellulose, Combination, Gelatin, Collagen), Application (Gynecology, Neurology, Cardiovascular, Reconstructive), Formulation (Powder, Matrix & Gel, Sheets & Pads) - Global Forecast to 2023", analyzes and studies the major market drivers, restraints/challenges, and opportunities. The hemostats market is expected to reach USD 3.03 billion by 2023 from USD 2.14 billion in 2017 at a CAGR of 6.0%. The global Hemostats market is segmented based on product, application, formulation, and re ...
